Standard BMI inadequate for ALL patientsFebruary 1, 2016Leukemia, Myelodysplasia, TransplantationPediatricsALL
Drug nets 3rd breakthrough designation from FDAJanuary 29, 2016Leukemia, Myelodysplasia, TransplantationPharmacyAML
Incorporating cultural beliefs into cancer careJanuary 29, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Appalachia has higher cancer incidence than rest of USJanuary 28, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated IssuesHodgkin Lymphoma
Compounds could treat leukemia, lymphomaJanuary 27, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
New insight into CLL developmentJanuary 25, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Fruit fly findings may have implications for leukemia, other cancersJanuary 24, 2016Leukemia, Myelodysplasia, Transplantation
Fertility concerns of AYA cancer survivorsJanuary 22, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
Protein may be therapeutic target for AMLJanuary 21, 2016Leukemia, Myelodysplasia, TransplantationAML
Drug granted another breakthrough designation for CLLJanuary 21, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
End-of-life cancer care by countryJanuary 21, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Drug approved to treat ALL in EUJanuary 20, 2016Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
FDA approves maintenance therapy for CLLJanuary 20, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma